About Journal of Neoplasms
Advancing cancer research from molecular discovery to clinical translation.
The Premier Platform for Cancer Research
Journal of Neoplasms (JN) is an open-access, peer-reviewed publication dedicated to accelerating the understanding and treatment of cancer. We connect oncologists, cancer biologists, translational researchers, and clinical investigators worldwide through high-impact research that transforms patient care.
From tumor biology to immunotherapy breakthroughs—advancing the frontiers of oncology.
The Journal of Neoplasms fosters rapid dissemination of significant research findings across all domains of cancer science. We publish high-quality, peer-reviewed articles that advance understanding of neoplasms at molecular, cellular, tissue, and clinical levels. Our editorial vision prioritizes research that bridges laboratory discovery with patient benefit.
Tumor Biology
Cancer genomics, epigenetics, oncogene pathways, tumor microenvironment, metastasis mechanisms, and cancer stem cell biology.
Therapeutic Innovation
Immunotherapy, CAR-T cells, targeted agents, antibody-drug conjugates, combination strategies, and resistance mechanisms.
Clinical Oncology
Clinical trials, precision medicine, biomarker development, survivorship research, palliative care, and health disparities.
Diagnostics
Liquid biopsy, molecular imaging, early detection biomarkers, prognostic markers, and companion diagnostics.
Why Publish in JN? Our global readership includes leading oncologists, research institutions, and pharmaceutical partners. Open access ensures your research reaches clinicians, policymakers, and patient advocacy groups worldwide—maximizing citation potential and real-world impact.
- Original research articles with novel findings
- Comprehensive reviews and systematic analyses
- Clinical trial reports and interim analyses
- Case reports with educational value
- Methods papers and technical innovations
- Commentaries and perspectives on emerging topics
Our editorial board comprises leading researchers and clinicians in oncology and cancer biology. Board members ensure rigorous peer review, maintain scientific integrity, and guide strategic direction. Every submission receives expert evaluation focused on methodology, reproducibility, and clinical relevance.
Ready to Publish Your Cancer Research?
Join the global oncology community advancing cancer diagnosis and treatment.
